These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 30621469

  • 1. A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses.
    Abdous M, Hasannia S, Salmanian AH, Shahryar Arab S, Shali A, Alizadeh GA, Hajizadeh A, Khafri A, Mohseni A.
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):25-31. PubMed ID: 30621469
    [Abstract] [Full Text] [Related]

  • 2. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
    Suryanarayana N, Verma M, Thavachelvam K, Saxena N, Mankere B, Tuteja U, Hmuaka V.
    Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
    [Abstract] [Full Text] [Related]

  • 3. Efficacy assessment of a triple anthrax chimeric antigen as a vaccine candidate in guinea pigs: challenge test with Bacillus anthracis 17 JB strain spores.
    Abdous M, Hasannia S, Salmanian AH, Arab SS.
    Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):495-502. PubMed ID: 34259590
    [Abstract] [Full Text] [Related]

  • 4. Development of a novel multiepitope chimeric vaccine against anthrax.
    Aggarwal S, Somani VK, Gupta S, Garg R, Bhatnagar R.
    Med Microbiol Immunol; 2019 Apr; 208(2):185-195. PubMed ID: 30671633
    [Abstract] [Full Text] [Related]

  • 5. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
    Varshney A, Kumar M, Nagar DP, Pal V, Goel AK.
    Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
    [Abstract] [Full Text] [Related]

  • 6. Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor.
    Taft SC, Weiss AA.
    Clin Vaccine Immunol; 2008 Jan; 15(1):71-5. PubMed ID: 18032590
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes.
    Nguyen ML, Terzyan S, Ballard JD, James JA, Farris AD.
    Infect Immun; 2009 Nov; 77(11):4714-23. PubMed ID: 19720758
    [Abstract] [Full Text] [Related]

  • 9. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T, Israeli M, Rotem S, Elia U, Bar-Haim E, Ehrlich S, Cohen O, Shafferman A.
    Vaccine; 2017 Oct 20; 35(44):6030-6040. PubMed ID: 28342664
    [Abstract] [Full Text] [Related]

  • 10. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
    Yan M, Roehrl MH, Basar E, Wang JY.
    Vaccine; 2008 Feb 13; 26(7):947-55. PubMed ID: 18192092
    [Abstract] [Full Text] [Related]

  • 11. Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
    Yin Y, Zhang J, Dong D, Liu S, Guo Q, Song X, Li G, Fu L, Xu J, Chen W.
    Vaccine; 2008 Oct 29; 26(46):5814-21. PubMed ID: 18786589
    [Abstract] [Full Text] [Related]

  • 12. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
    Gaur R, Gupta PK, Banerjea AC, Singh Y.
    Vaccine; 2002 Jun 21; 20(21-22):2836-9. PubMed ID: 12034111
    [Abstract] [Full Text] [Related]

  • 13. A chimeric protein that functions as both an anthrax dual-target antitoxin and a trivalent vaccine.
    Wu G, Hong Y, Guo A, Feng C, Cao S, Zhang CC, Shi R, Tan Y, Liu Z.
    Antimicrob Agents Chemother; 2010 Nov 21; 54(11):4750-7. PubMed ID: 20713663
    [Abstract] [Full Text] [Related]

  • 14. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
    Hermanson G, Whitlow V, Parker S, Tonsky K, Rusalov D, Ferrari M, Lalor P, Komai M, Mere R, Bell M, Brenneman K, Mateczun A, Evans T, Kaslow D, Galloway D, Hobart P.
    Proc Natl Acad Sci U S A; 2004 Sep 14; 101(37):13601-6. PubMed ID: 15342913
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.
    Park YS, Lee JH, Hung CF, Wu TC, Kim TW.
    Infect Immun; 2008 May 14; 76(5):1952-9. PubMed ID: 18285494
    [Abstract] [Full Text] [Related]

  • 16. Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera.
    Verma M, Suryanarayana N, Tuteja U, Thavachelvam K, Rao MK, Bhargava R, Shukla S.
    Toxicon; 2017 Dec 01; 139():58-65. PubMed ID: 28919458
    [Abstract] [Full Text] [Related]

  • 17. Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization.
    Dumas EK, Nguyen ML, Cox PM, Rodgers H, Peterson JL, James JA, Farris AD.
    Vaccine; 2013 Apr 03; 31(14):1856-63. PubMed ID: 23415781
    [Abstract] [Full Text] [Related]

  • 18. An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor.
    Baillie LW, Huwar TB, Moore S, Mellado-Sanchez G, Rodriguez L, Neeson BN, Flick-Smith HC, Jenner DC, Atkins HS, Ingram RJ, Altmann DM, Nataro JP, Pasetti MF.
    Vaccine; 2010 Sep 24; 28(41):6740-8. PubMed ID: 20691267
    [Abstract] [Full Text] [Related]

  • 19. Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays.
    Pohl MA, Rivera J, Nakouzi A, Chow SK, Casadevall A.
    Infect Immun; 2013 Jun 24; 81(6):1880-8. PubMed ID: 23509144
    [Abstract] [Full Text] [Related]

  • 20. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J, Grover S, Goel D, Rahi A, Jayadev Magani SK, Chandra S, Bhatnagar R.
    Vaccine; 2011 Jun 15; 29(27):4521-33. PubMed ID: 21504775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.